Increasing the class of foundational medication for heart failure is associated with improved prognosis in hospitalized patients with heart failure with reduced or mildly reduced ejection fraction
Authors: M Ito, D Maeda, Y Matsue, Y Shiraishi, T Dotare, T Sunayama, K Nogi, S Kohsaka, T Yoshikawa, Y Saito, T Minamino